// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Good outcomes following elective lower limb orthopaedic surgery in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension

Mikaela Ming - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Chronic thromboembolic pulmonary hypertension

N/A

Lung epithelial microvesicles induced by pneumolysin contain mitochondrial cargo

Eleftheria Letsiou - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Acute lung injury

N/A

The association of respiratory health and cardiovascular risk with structural brain disease in patients with COPD

Daniel Burrage - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Arterial stiffness

N/A

Cardiopulmonary exercise testing (CPET) patient survey

Jeanette Boyd - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Cystic Fibrosis

N/A

Routine liver function test monitoring of patients treated for active M.TB infection does not influence management: A real-world retrospective study

Eshrina Gosal - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Cardiovascular safety of fixed dose combination long acting bronchodilators in stable patients with Chronic Obstructive Pulmonary Disease.

Sudip Ghosh - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

T2-endotype predicts bronchodilator (BD) response in Exercise-Induced Bronchoconstriction (EIB)

Matteo Bonini - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

Ipratropium

New evidence of genetic adaptation to high altitude in Andean populations

Christina Eichstaedt - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Occupational tuberculosis screening for healthcare workers in a UK centre

Mimi Li - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Tuberculosis

N/A

DuoResp Spiromax adherence, satisfaction and ease of use: findings from a multi-country observational study in patients with asthma and COPD (SPRINT)

Job van der Palen - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Asthma

DuoResp Spiromax

Impact of initiation of a home oxygen service on oxygen cylinder refills and use of urgent orders

Claire Davey - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Clinical management of patients newly diagnosed with COPD through targeted case finding and routine care: a longitudinal analysis of the TargetCOPD trial

Shamil Haroon - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Nurse led lung cancer diagnostic/supportive follow up clinic;a different approach to optimise lung cancer pathway

Sarah Kerr - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Lung Cancer

N/A

Nontuberculous mycobacterial disease within UK primary care, 2006-2016

Eleanor Axson - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Myofibroblasts are associated with increase in small airway thickening, epithelial plasticity and decreased lung function in COPD

Mathew Eapen - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

DE-074

Gender aspects in quality of life of lung cancer patients

Myriam Koch - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Lung Cancer

N/A

CPAP related intraocular pressure increase at night in people with and without glaucoma.

Dariusz Wozniak - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Ophthalmology (OP)

Glaucoma

N/A

Effect of erdosteine in moderately severe COPD patients

Peter M.A. Calverley - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

Erdosteine

Active smoking and a past myocardial infarction status induce more vulnerability to urban heat stress in COPD

Christian Witt - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Myocardial infarction

N/A

Inter-individual variability in breathlessness perception in chronic obstructive pulmonary disease

Peter Siu Pan Cho - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Copyright © 2026. QuantiNova All rights reserved